Amgen (AMGN)
(Delayed Data from NSDQ)
$296.88 USD
+1.78 (0.60%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $296.81 -0.07 (-0.02%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth D Momentum B VGM
Fundamental Charts
About Market Cap
As of the previous market close, Amgen Inc. has a market cap of $158.68B, which represents its share price of $295.10 multiplied by its outstanding shares number of 537.71M. As a large-cap company, AMGN's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
AMGN 296.88 +1.78(0.60%)
Will AMGN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AMGN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AMGN
Why This 1 Growth Stock Could Be a Great Addition to Your Portfolio
Gear Up for Amgen (AMGN) Q2 Earnings: Wall Street Estimates for Key Metrics
AMGN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Alvotech Gears Up to Report Q2 Earnings: Here's What to Expect
Analysts Estimate MannKind (MNKD) to Report a Decline in Earnings: What to Look Out for
Amgen Gears Up to Report Q2 Earnings: Will the Beat Streak Continue?
Other News for AMGN
Market Voices: Trump vs. Big Pharma, Swiss tariffs, tariff legality
Trump Trade: Trump signs executive order raising tariff on Canada to 35%
Amgen Inc (AMGN) Declares Third Quarter 2025 Dividend | AMGN stock news
AMGEN ANNOUNCES 2025 THIRD QUARTER DIVIDEND | AMGN Stock News
Trump Issues 60 Day Ultimatum To US Pharma Giants To Slash Drug Prices: 'If You Refuse To Step Up We Will...'